200 related articles for article (PubMed ID: 33832435)
1. The inhibitory receptor Tim-3 fails to suppress IFN-γ production via the NFAT pathway in NK-cell, unlike that in CD4
Yu X; Lang B; Chen X; Tian Y; Qian S; Zhang Z; Fu Y; Xu J; Han X; Ding H; Jiang Y
BMC Immunol; 2021 Apr; 22(1):25. PubMed ID: 33832435
[TBL] [Abstract][Full Text] [Related]
2. NK cell expression of Tim-3: First impressions matter.
So EC; Khaladj-Ghom A; Ji Y; Amin J; Song Y; Burch E; Zhou H; Sun H; Chen S; Bentzen S; Hertzano R; Zhang X; Strome SE
Immunobiology; 2019 May; 224(3):362-370. PubMed ID: 30876792
[TBL] [Abstract][Full Text] [Related]
3. A Novel Toll-Like Receptor 9 Agonist, MGN1703, Enhances HIV-1 Transcription and NK Cell-Mediated Inhibition of HIV-1-Infected Autologous CD4+ T Cells.
Offersen R; Nissen SK; Rasmussen TA; Østergaard L; Denton PW; Søgaard OS; Tolstrup M
J Virol; 2016 May; 90(9):4441-4453. PubMed ID: 26889036
[TBL] [Abstract][Full Text] [Related]
4. Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9.
Gleason MK; Lenvik TR; McCullar V; Felices M; O'Brien MS; Cooley SA; Verneris MR; Cichocki F; Holman CJ; Panoskaltsis-Mortari A; Niki T; Hirashima M; Blazar BR; Miller JS
Blood; 2012 Mar; 119(13):3064-72. PubMed ID: 22323453
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.
Cheng YQ; Ren JP; Zhao J; Wang JM; Zhou Y; Li GY; Moorman JP; Yao ZQ
Immunology; 2015 Aug; 145(4):485-97. PubMed ID: 25772938
[TBL] [Abstract][Full Text] [Related]
6. Tim-3 and PD-1 blocking cannot restore the functional properties of natural killer cells in early clinical stages of chronic lymphocytic leukemia: An
Astaneh M; Rezazadeh H; Hossein-Nataj H; Shekarriz R; Zaboli E; Shabani M; Asgarian-Omran H
J Cancer Res Ther; 2022; 18(3):704-711. PubMed ID: 35900543
[TBL] [Abstract][Full Text] [Related]
7. TIM-3 Suppresses Anti-CD3/CD28-Induced TCR Activation and IL-2 Expression through the NFAT Signaling Pathway.
Tomkowicz B; Walsh E; Cotty A; Verona R; Sabins N; Kaplan F; Santulli-Marotto S; Chin CN; Mooney J; Lingham RB; Naso M; McCabe T
PLoS One; 2015; 10(10):e0140694. PubMed ID: 26492563
[TBL] [Abstract][Full Text] [Related]
8. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B.
Ju Y; Hou N; Meng J; Wang X; Zhang X; Zhao D; Liu Y; Zhu F; Zhang L; Sun W; Liang X; Gao L; Ma C
J Hepatol; 2010 Mar; 52(3):322-9. PubMed ID: 20133006
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.
Lee MJ; Woo MY; Chwae YJ; Kwon MH; Kim K; Park S
Immunobiology; 2012 Oct; 217(10):986-95. PubMed ID: 22445722
[TBL] [Abstract][Full Text] [Related]
10. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders.
de Kivit S; Lempsink LJ; Plants J; Martinson J; Keshavarzian A; Landay AL
Clin Immunol; 2015 Jan; 156(1):28-35. PubMed ID: 25450337
[TBL] [Abstract][Full Text] [Related]
11. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
Holder KA; Lajoie J; Grant MD
Front Immunol; 2018; 9():2494. PubMed ID: 30483249
[TBL] [Abstract][Full Text] [Related]
12. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
13. Tim-3 negatively mediates natural killer cell function in LPS-induced endotoxic shock.
Hou H; Liu W; Wu S; Lu Y; Peng J; Zhu Y; Lu Y; Wang F; Sun Z
PLoS One; 2014; 9(10):e110585. PubMed ID: 25337993
[TBL] [Abstract][Full Text] [Related]
14. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.
Sakhdari A; Mujib S; Vali B; Yue FY; MacParland S; Clayton K; Jones RB; Liu J; Lee EY; Benko E; Kovacs C; Gommerman J; Kaul R; Ostrowski MA
PLoS One; 2012; 7(7):e40146. PubMed ID: 22792231
[TBL] [Abstract][Full Text] [Related]
15. Higher NK cell IFN-γ production is associated with delayed HIV disease progression in LTNPs.
Jiang Y; Zhou F; Tian Y; Zhang Z; Kuang R; Liu J; Han X; Hu Q; Xu J; Shang H
J Clin Immunol; 2013 Nov; 33(8):1376-85. PubMed ID: 23996459
[TBL] [Abstract][Full Text] [Related]
16. TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4
Duan S; Xu X; Wang J; Huang L; Peng J; Yu T; Zhou Y; Cheng K; Liu S
J Virol; 2021 Aug; 95(17):e0081621. PubMed ID: 34133900
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Th1 T Cell Differentiation by Iron
Pfeifhofer-Obermair C; Tymoszuk P; Nairz M; Schroll A; Klais G; Demetz E; Engl S; Brigo N; Weiss G
Front Immunol; 2021; 12():637809. PubMed ID: 34108960
[TBL] [Abstract][Full Text] [Related]
18. The Education of NK Cells Determines Their Responsiveness to Autologous HIV-Infected CD4 T Cells.
Kiani Z; Dupuy FP; Bruneau J; Lebouché B; Retière C; Geraghty DE; Bernard NF
J Virol; 2019 Dec; 93(23):. PubMed ID: 31511383
[TBL] [Abstract][Full Text] [Related]
19. Tim-3 pathway affects NK cell impairment in patients with active tuberculosis.
Wang F; Hou H; Wu S; Tang Q; Huang M; Yin B; Huang J; Liu W; Mao L; Lu Y; Sun Z
Cytokine; 2015 Dec; 76(2):270-279. PubMed ID: 26050547
[TBL] [Abstract][Full Text] [Related]
20. CD4+ T-cell help enhances NK cell function following therapeutic HIV-1 vaccination.
Jost S; Tomezsko PJ; Rands K; Toth I; Lichterfeld M; Gandhi RT; Altfeld M
J Virol; 2014 Aug; 88(15):8349-54. PubMed ID: 24829350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
